GlobalData on MSN17d
Sage rejects Biogen’s $469m takeover bidSage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of shareholders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback